These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 7805759

  • 21. Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier.
    Héron C, Costentin J, Bonnet JJ.
    Eur J Pharmacol; 1994 Nov 03; 264(3):391-8. PubMed ID: 7698180
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. O-526, a piperidine analog of GBR 12909, retains high affinity for the dopamine transporter in monkey caudate-putamen.
    Madras BK, Reith ME, Meltzer PC, Dutta AK.
    Eur J Pharmacol; 1994 Apr 15; 267(2):167-73. PubMed ID: 8050478
    [Abstract] [Full Text] [Related]

  • 25. [3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP): a new phencyclidine analog selective for the dopamine uptake complex.
    Vignon J, Pinet V, Cerruti C, Kamenka JM, Chicheportiche R.
    Eur J Pharmacol; 1988 Apr 13; 148(3):427-36. PubMed ID: 3384005
    [Abstract] [Full Text] [Related]

  • 26. In vivo labelling of the neuronal dopamine uptake complex in the mouse striatum by [3H]GBR 12783.
    Vaugeois JM, Bonnet JJ, Costentin J.
    Eur J Pharmacol; 1992 Jan 07; 210(1):77-84. PubMed ID: 1350989
    [Abstract] [Full Text] [Related]

  • 27. Specific binding of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl propyl) piperazine (GBR-12935), an inhibitor of the dopamine transporter, to human CYP2D6.
    Hiroi T, Imaoka S, Chow T, Yabusaki Y, Funae Y.
    Biochem Pharmacol; 1997 Jun 15; 53(12):1937-9. PubMed ID: 9256169
    [Abstract] [Full Text] [Related]

  • 28. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909).
    Matecka D, Rothman RB, Radesca L, de Costa BR, Dersch CM, Partilla JS, Pert A, Glowa JR, Wojnicki FH, Rice KC.
    J Med Chem; 1996 Nov 22; 39(24):4704-16. PubMed ID: 8941383
    [Abstract] [Full Text] [Related]

  • 29. Comparison of the effects of three indirect dopamine agonists, GK 13, GBR 12783 and dexamphetamine on behavioural tests involving central catecholaminergic transmissions.
    Duterte-Boucher D, Kamenka JM, Costentin J.
    Psychopharmacology (Berl); 1990 Nov 22; 101(3):344-53. PubMed ID: 1972995
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion.
    Vaugeois JM, Bonnet JJ, Duterte-Boucher D, Costentin J.
    Eur J Pharmacol; 1993 Jan 12; 230(2):195-201. PubMed ID: 8422901
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. In vitro and in vivo characterization of newly developed iodinated 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]piperazine derivatives in rats: limited value as dopamine transporter SPECT ligands.
    Rijks LJ, Booij J, Doornbos T, Boer GJ, Ronken E, de Bruin K, Vermeulen RJ, Janssen AG, Van Royen EA.
    Synapse; 1996 Jul 12; 23(3):201-7. PubMed ID: 8807748
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter.
    Gordon I, Weizman R, Rehavi M.
    Eur J Pharmacol; 1996 Feb 29; 298(1):27-30. PubMed ID: 8867915
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
    Pristupa ZB, Wilson JM, Hoffman BJ, Kish SJ, Niznik HB.
    Mol Pharmacol; 1994 Jan 29; 45(1):125-35. PubMed ID: 8302271
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Characterization of a recombinant human dopamine transporter in multiple cell lines.
    Eshleman AJ, Neve RL, Janowsky A, Neve KA.
    J Pharmacol Exp Ther; 1995 Jul 29; 274(1):276-83. PubMed ID: 7616409
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.